RC Compounding Services, LLC
Letter data
- Company
- RC Compounding Services, LLC
- Recipient
- Raymond R. Carlson, RPh | Owner/Pharmacist | RC Compounding Services, LLC | 3030 Center Road | Poland | , | OH | 44514 | United States
- Issue date
- 2019-09-12
- Posted date
- Not available
- FDA office
- Division of Pharmaceutical Quality Operations III
- Subject
- Not available
- Product
- Drugs
- CMS ID
- 393791
- Reference number
- CIN-14-393791-17
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
RC Compounding Services, LLC
MARCS-CMS 393791 —
September 12, 2019
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
UPS Next Day
Reference #:
CIN-14-393791-17
Product:
Drugs
Recipient:
Recipient Name
Raymond R. Carlson, RPh
Recipient Title
Owner/Pharmacist
RC Compounding Services, LLC
3030 Center Road
Poland
,
OH
44514
United States
Issuing Office:
Division of Pharmaceutical Quality Operations III
300 River Place
Suite 5900
Detroit
,
MI
48207
United States
(313) 393-8100
Dear Mr. Carlson,
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter dated July 14, 2014 (CIN-14-393791-17). Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Nicholas F. Lyons
Director Compliance Branch
Division of Pharmaceutical Quality Operations III
Content current as of:
10/24/2019
Regulated Product(s)
Drugs